"For more than a decade, The Center for Cancer & Blood Disorders has brought the finest cancer treatment to families in Parker County. Our Weatherford location offers both radiation therapy and chemotherapy through our team of five cancer specialists."

During the past decade, The Center for Cancer and Blood Disorders conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Cancer and Blood Disorders" #1 collaborator was "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Cancer and Blood Disorders" are "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Neoplasms" (1 trials) and "Clear Cell Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "The Center for Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "The Center for Cancer and Blood Disorders" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Anastrozole" (1 trials), "Bevacizumab" (1 trials), "Everolimus" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Cancer and Blood Disorders" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Center for Cancer and Blood Disorders". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Center for Cancer and Blood Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".